Clinical Director of Leukemia Services at University of Colorado
Hematology
Dr. Daniel A. Pollyea, MD
|
|
Give Review
Daniel A. Pollyea, MD is an expert in the field of Hematology. He went to University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Daniel A. Pollyea, MD is a published physician. He published 26 publications, including: 'SomVarIUS: Somatic variant identification from unpaired tissue samples.' Daniel Pollyea accepts all Medicare patients.
Publications
- SomVarIUS: Somatic variant identification from unpaired tissue samples.
- Clonality of neutrophilia associated with plasma Cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
- Tyrosine kinase inhibition in Leukemia induces an altered metabolic state sensitive to mitochondrial perturbations.
- Myelodysplastic syndromes, version 2.2015.
- Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks.
- Inhibition of calcineurin combined with dasatinib has direct and indirect anti-Leukemia effects against BCR-ABL1(+) Leukemia.
- Aldehyde dehydrogenases in Acute myeloid leukemia.
- Omacetaxine mepesuccinate for the treatment of chronic myeloid Leukemia.
- Oncogenic CSF3R mutations in chronic neutrophilic Leukemia and atypical CML.
- Sequential azacitidine plus lenalidomide combination for elderly patients with untreated Acute myeloid leukemia.
- Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive Acute lymphoblastic leukemia.
- Adjusting DLCO for Hb and its effects on the Hematopoietic Cell Transplantation-specific Comorbidity Index.
- 2-Hydroxyglutarate in IDH mutant Acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylc...
- Reactive oxygen species regulate nucleostemin oligomerization and protein degradation.
- Second-line mitoxantrone, etoposide, and cytarabine for Acute myeloid leukemia: a single-center experience.
- Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitors.
- Utility of influenza vaccination for oncology patients.
- When yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stings.
- Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic Cell transplantation.
- TNP-470 promotes initial vascular sprouting in xenoGraft tumors.
- The effects of alcohol and aldehyde dehydrogenases on Disorders of hematopoiesis.
- Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
- Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic Cell transplantation.
- Chimerism does not predict for outcome after alemtuzumab based conditioning.
- Acute myeloid leukaemia in the elderly: a review.
Schools
University Of Chicago Division Of The Biological Sciences The Pritzker School Of Medicine
John H Stroger Hospital Of Cook County Program
University Of Chicago Program
Stanford University Program
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Bladder Cancer
- Central Nervous System Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Cofinity PPO
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Individual and Family PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1801915822 | |
| NPPES Provider LastName | POLLYEA | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 185.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801915822 |
| Last Name Of The Provider | POLLYEA |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
Dr. Paul A. Bunn Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vu H. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn L. Hassell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William E. Daniel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elaine T. Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter Kabos, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. L Michael Glode, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Manoj Pillai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jan L. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John Burke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ana B. Oton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manali K. Kamdar, MD |
|
Dr. Nicholas J. Dibella, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew T. Johnson, MD |
|
|
Dr. Angela M. Davies, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Zohra I. Nooruddin, MD |